Results 181 to 190 of about 27,256 (249)

PDB70 EVALUATION OF SITAGLIPTIN DOSING AMONG RENAL IMPAIRED TYPE 2 DIABETES MELLITUS PATIENTS

, 2010
Girishanthy Krishnarajah, Christopher M. Dezii, Martin Tran, BA Balar   +3 more
openalex   +1 more source

Simultaneous Determination and Stability Assessment of Metformin and Sitagliptin in Pharmaceutical Form by High Performance Liquid Chromatography = التحديد المتزامن للميتفورمين والسيتاجلبتين في الشكل الصيدلاني باستخدام الكروماتوغرافيا السائلة عالية الأداء

, 2017
Akef T. Afaneh, Fawaz Deabas, Ali M. Qaisi   +2 more
openalex   +1 more source

Real-World Evaluation of Early Initiation of Dapagliflozin and Sitagliptin Combination Therapy in the Management of Type 2 Diabetes Mellitus (REALIZE Study). [PDF]

Cureus
Das S, Ramachandran A, Wangnoo SK, Deb P, Kadam Y, Pednekar A, Kesarkar RN.   +6 more
europepmc   +1 more source

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus. [PDF]

Pharmacoepidemiol Drug Saf
Aloke C, Adelusi OA, Onisuru OO, Iwuchukwu EA, Achilonu I.   +4 more
europepmc   +1 more source

NiO/CuO@Graphene oxide-modified electrode for sensitive detection of an antidiabetic drug. [PDF]

Sci Rep
Labeeb EN, Hefnawy MA, Medany SS, Frag EY.   +3 more
europepmc   +1 more source

Cost effectiveness analysis of six non insulin agents for type 2 diabetes in Iran using a patient level simulation with UKPDS OM2. [PDF]

Sci Rep
Darvishi A, Daroudi R, Dehghan S, Heshmat R, Shafiee G.   +4 more
europepmc   +1 more source

Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis. [PDF]

Cureus
Prakash V, Goel N.
europepmc   +1 more source

Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). [PDF]

Diabetes Care
Kahn SE, Tripputi M, Lachin JM, Balasubramanyam A, Banerji MA, Barzilay J, Cohen RM, Garvey WT, Gramzinski MR, Rasouli N, Rhee M, Seegmiller JC, Singh V, Sivitz WI, Steffes MW, Utzschneider K, DeFronzo RA, GRADE Research Group* .   +17 more
europepmc   +1 more source

Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice. [PDF]

Nat Med
Krüger N, Schneeweiss S, Desai RJ, Sreedhara SK, Kehoe AR, Fuse K, Hahn G, Schunkert H, Wang SV.   +8 more
europepmc   +1 more source

Unraveling the Antihyperglycemic Effects of Dipeptyl Peptidase-4 Inhibitors in Rodents: A Multi-Faceted Approach Combining Effects on Glucose Homeostasis, Molecular Docking, and ADMET Profiling. [PDF]

Pharmaceuticals (Basel)
Roriz RNS, Cardozo CJP, Freire GA, Martins CBR, Filho RRBX, Pereira LL, Rangel GFP, Sampaio TL, Ribeiro LR, Silva GS, Maia I, Wong DVT, Sousa DOB, de Oliveira AC, Reina E, Lima LM, Peláez W, da Rocha MN, Marinho MM, Santos HSD, Marinho ES, de Menezes JESA, Silva FRMB, Canuto KM, Alencar NMN, Frederico MJS.   +25 more
europepmc   +1 more source